Instrument Inactif

Autres langues Syneos Health, Inc.

Actions

SYNH

US87166B1026

Recherche biotechnologique et médicale

Autres langues

16/09	Syneos Health Reports Results Of Benchmarking Study On Clinical Trial Sourcing Models
18/08	Syneos Health Advances Ai-Powered Clinical Ecosystem to Optimize Trial Performance and Speed Decision-Making
18/08	Causaly and Syneos Health Enter Strategic Partnership to Raise Scientific Intensity of Clinical Research
28/05	Syneos Health, Inc. Announces Appointment of Greg Licholai as Chief Medical Officer, Effective June 1, 2026
19/05	Helio Genomics And Syneos Health Enter Commercial Partnership To Accelerate Nationwide Adoption Of HelioLiver
14/05	Syneos Health Expands Strategic AI Partnerships
07/05	CausaLens and Syneos Health Expand Strategic Partnership to Scale Agentic AI in Biopharma Commercialization
30/04	Kai Conversations and Syneos Health Form Strategic Partnership to Advance U.S. Pharmaceutical Commercialization
20/03	Syneos Health, Inc. acquired Shanghai Bestudy Medical Technology Co., Ltd.
20/03	Big Bidders Reportedly Line Up for Nucleus Network
08/01	Syneos Health, Inc. Appoints Simon Bartle as Chief Human Resources Officer, Effective January 8, 2026
21/10/25	Caremetx and Syneos Health Unite to Accelerate Patient Access
09/10/24	Syneos Health Announces Chief Executive Officer Changes
09/10/24	Syneos Health, Inc. Announces Board Appointments
04/10/24	CytoDyn Inc. Engages Syneos Health as CRO for Its Phase II Oncology Trial
08/07/24	Syneos Health : Releases 2023 Environmental, Social and Governance Report
10/01/24	Syneos Health Releases 2024 Dealmakers Intentions Survey
18/12/23	Syneos Health : Signs Agreement with University of the Sunshine Coast to Support Clinical Trials in Australia
03/11/23	Syneos Health : Signs Agreement with P3 Research Ltd Network to Support Clinical Trials in New Zealand
02/11/23	Syneos Health : Signs Agreement with GoBroad Healthcare Group to Support Clinical Trials in China
30/10/23	Syneos Health Signs Agreement with Singapore General Hospital, Further Expanding Catalyst Site Program
04/10/23	Syneos Health Appoints Colin Shannon as Chief Executive Officer
03/10/23	Syneos Health Names Colin Shannon CEO
03/10/23	Syneos Health, Inc. Announces Chief Executive Officer Changes
29/09/23	Syneos Health, Inc.(NasdaqGS:SYNH) dropped from S&P 400